Long Island Doctor Pleads Guilty To Conspiracy To Distribute Oxycodone
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Long Island Doctor Pleads Guilty To Conspiracy To Distribute Oxycodone

Long Island Doctor Pleads Guilty To Conspiracy To Distribute Oxycodone

July 11, 2013
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: 862-373-3557

Dr. William Conway issued over 782,000 oxycodone pills illegally to patients; two patients died of oxycodone overdoses in 2011

JULY 11-William J. Conway, a Baldwin, New York physician, pled guilty today in United States District Court for the Eastern District of New York to conspiring to illegally distribute the highly addictive painkiller oxycodone to patients, who the defendant knew were addicts and without performing any meaningful medical examination. When sentenced, Conway faces up to 20 years in prison, a $1 million fine and loss of his license to practice medicine.

The guilty plea was announced by Brian R. Crowell, Special Agent in Charge of the U.S. Drug Enforcement (DEA), New York Division, Loretta E. Lynch, United States Attorney for the Eastern District of New York, and Thomas V. Dale, Commissioner, Nassau County Police Department. The plea was entered before the Honorable Leonard D. Wexler at the United States Courthouse in Central Islip, New York.
Conway was arrested on June 6, 2012 as part of the Eastern District of New York’s Prescription Drug Initiative, led by the United States Attorney’s Office and the DEA, working with the Nassau County Police Department, the New York State Police and numerous other local, state and federal law enforcement agencies. He has been held in custody since the arrest.

According to court filings and records of the New York State Bureau of Narcotics Enforcement, between January 2009 and November 2011, Conway issued 5,554 oxycodone prescriptions - for a total of 782,032 pills - to numerous individuals. During the execution of a federal search warrant at his offices on March 1, 2012, Conway surrendered his DEA registration authorizing him to prescribe controlled substances. Despite that surrender, Conway continued to engage in the conspiracy to illegally distribute oxycodone after that date.

On April 23, 2011, Giovanni Manzella, a 34 year-old man from Long Beach, New York, died of an overdose of oxycodone less than 48 hours after Conway provided him with two prescriptions totaling 450 pills. On October 27, 2011, 29 year-old Christopher Basmas of Hicksville, New York was pronounced dead of an overdose, also within two days after receiving a prescription from Conway for 180 pills of oxycodone. Patient files seized by the DEA revealed that neither man received meaningful medical examinations from Conway. The files for these and other patients typically consisted of little more than notations of a patient’s height, weight and blood pressure. After Basmas’ death, Conway attempted to alter patient files to cover his tracks, but still continued to issue prescriptions - in some instances, in the names of individuals he had never treated, or even met.

In September 2012, Conway’s office assistant, Robert Hachemeister, was charged with conspiring with Conway to illegally distribute oxycodone, and with distributing oxycodone to Conway’s patients. Hachemeister, who had worked as an office assistant for Conway since approximately 1995, distributed thousands of oxycodone pills using prescription pads that were pre-signed by Conway between 2011 and 2012. On January 9, 2013, Hachemeister pled guilty to conspiring to illegally distribute oxycodone and is currently awaiting sentencing.

DEA Special Agent in Charge Crowell stated, “One of DEA’s top priorities is to stop overdoses and deaths by fully identifying and prosecuting those responsible for putting diverted drugs in the hands of those abusing opiates. Dr. Conway has been tied to local overdoses that bring home the enormity of the country’s prescription pill epidemic. One out of every ten high school seniors has abused oxycodone or hydrocodone for recreational use. Investigating rogue doctors and increasing the awareness of the dangers associated with Rx abuse are two significant steps our law enforcement team takes to curtail this problem and to protect our communities.”

“Instead of providing needed medical services to his community, Dr. Conway directly contributed to the tragedy of prescription drug abuse that has swept across our district and our nation. On Conway’s watch, oxycodone pills might as well have been mints in a candy jar. Even the death of his patients only led him to try to conceal his actions, rather than truly care for his patients. Today’s conviction should serve as a warning to those who would violate their oath as medical professionals to do no harm: if you illegally distribute prescription drugs, you will be held accountable,” stated United States Attorney Lynch. “I want to thank our partners at the DEA, Nassau County Police and the New York State Police for their effective work in investigating this case.”

The Prescription Drug Initiative is a joint effort led by the United States Attorney’s Office for the Eastern District of New York, the DEA and the five District Attorneys in Kings, Nassau, Queens, Richmond and Suffolk Counties, working in conjunction with the New York City Police Department and the Nassau and Suffolk County Police Departments, as well as the Department of Health and Human Services, the Internal Revenue Service, New York/New Jersey HIDTA, the New York State Department of Health and the New York State Medicaid Inspector General. The Prescription Drug Initiative is a broad and comprehensive approach to the epidemic of prescription drug trafficking and abuse, involving not only criminal investigation and prosecution at the federal, state and local level, but also the targeted use of civil law enforcement, regulatory action and community outreach. The Initiative has expanded information-sharing among federal and state enforcement agencies to better identify and target suspected traffickers, and ensure greater use of criminal, civil, forfeiture, injunctive and other tools.
The government’s case is being prosecuted by Assistant United States Attorneys Sean C. Flynn and Michael P. Canty.

The Defendant -
Name: WILLIAM J. CONWAY

Age: 70


Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Frank A. Tarentino III Special Agent in Charge - New York
@DEANewYorkDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español